genvoya
Selected indexed studies
- Genvoya-Associated and Simvastatin-Associated Noninflammatory and Nonautoimmune Myopathy: A Case Report and Literature Review. (J Clin Neuromuscul Dis, 2022) [PMID:36409337]
- Bictegravir. (Curr Opin HIV AIDS, 2018) [PMID:29746268]
- Overdose of the HIV Medicine Genvoya® in Two Auto-Intoxications. (J Anal Toxicol, 2023) [PMID:35921238]
_Worker-drafted node — pending editorial review._
Connections
genvoya is a side effect of
Sources
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. (2017) pubmed
- Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. (2025) pubmed
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial. (2023) pubmed
- Bictegravir. (2018) pubmed
- Tenofovir Alafenamide. (2016) pubmed
- Genvoya-Associated and Simvastatin-Associated Noninflammatory and Nonautoimmune Myopathy: A Case Report and Literature Review. (2022) pubmed
- Overdose of the HIV Medicine Genvoya® in Two Auto-Intoxications. (2023) pubmed
- A Review of the Efficacy and Safety of Genvoya® (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection. (2018) pubmed
- Introducción. Darunavir, cobicistat, emtricitabina y tenofovir alafenamida coformulados en el tratamiento de la infección por el VIH. (2018) pubmed
- Genvoya--a new 4-drug combination for HIV. (2016) pubmed